The present disclosure is directed to a method and apparatus for separating biological materials, and particularly to a system for separating a selected fraction from a multiple-component biological material.
This section provides background information that is related to the present disclosure, but that is not necessarily prior art.
Various cellular (or biological) materials can be used to assist a healing or recovery process in a human patient. Selected cell types, such as stromal cells, pluripotent or multipotent stem cells, or fully differentiated cells, can be applied therapeutically to the patient. For example, stem cells can be applied to an affected area of the patient, such as an area that may be damaged due to injury, chemotherapy, or radiation therapy, to assist in healing the area through differentiation of the stem cells and regeneration of the affected cells.
In performing a therapeutic procedure on a human patient using undifferentiated cells, such as stem cells or stromal cells, the undifferentiated cells can be obtained from various sources, including the patient's own anatomy. Accordingly, certain autologous cells can be applied to or injected into various portions of the anatomy of the patient. Generally, a whole tissue or whole blood sample can be obtained from the patient during a first procedure, selected cells can be separated from the whole tissue or blood sample, and the selected, separated cells can be reapplied to or injected into the patient during a subsequent procedure.
This section provides a general summary of aspects of the invention, and is not a comprehensive description of its full scope or all of its features.
According to various embodiments, a system can be provided to separate undifferentiated cells, including stem cells and/or stromal cells, from a whole tissue or whole blood sample. The sample can be any appropriate tissue or blood sample obtained directly from a patient. The sample can be obtained during a selected operating procedure with the object of separating undifferentiated cells from the sample for immediate or quick application to the patient. Accordingly, autologous undifferentiated cells can be obtained intra-operatively for application to a patient relatively soon after obtaining a whole tissue or whole blood sample.
Further areas of applicability will become apparent from the description provided herein. The description and specific examples are intended for purposes of illustration only and are not intended to define the scope of the claimed invention.
The drawings described herein are for illustrative purposes only of selected embodiments and not all possible implementations, and are not intended to limit the scope of the present disclosure.
Corresponding reference numerals indicate corresponding parts throughout the several views of the drawings.
Example embodiments will now be described more fully with reference to the accompanying drawings.
With reference to
The separating system 20 can include a buoy system 30 positionable within the container 22 and able to move generally axially along the longitudinal axis A relative to the bottom wall 26 and the top wall 28. Buoy system 30 can be configured to contact, in a desired, selected manner, an inner wall surface 32 of the wall 24. For example, the buoy system 30 can be configured to frictionally engage the inner wall surface 32 while separating system 20 is in a substantially static state, and yet move axially relatively freely with respect to the container 22 while separating system 20 is being centrifuged, as described further below. According to various embodiments, the container 22 can be formed of a material selected such that wall 24 can flex outwardly and transversely to the longitudinal axis A, under a selected force. For example, as disclosed in U.S. Pat. No. 7,374,678, issued May 20, 2008, incorporated herein by reference, the container 22 can be positioned in a centrifuge and spun so that a large force, generally several times that of gravity, is applied towards the bottom wall 26 of the container 22 so that the wall 24 flexes outwardly and container 22 compresses. In the compressed state, the cylindrical outer wall 24 can expand in diameter such that inner wall surface 32 can move radially away from the buoy system 30. Consequent clearance between buoy system 30 and inner wall surface 32 allows buoy system 30 to move axially within the container 22 and relative to the inner wall surface 32.
The buoy system 30, as discussed in further detail herein, can include or define a separation or collection volume 40 between an upper buoy portion or member 42 and a lower buoy portion or member 44. A withdrawal member or tube 46 can interconnect a withdrawal port 48 with an extraction port 50 associated with the buoy system 30. The withdrawal port 48 can extend through the top wall 28 to an exterior of the container and the extraction port 50 can communicate with and allow access to the collection volume 40 within the buoy 30. The withdrawal port 48 can include a connector, such as a luer connector 52, that can be selectively capped or blocked with a cap or plug 54.
An introduction port 56 can also extend through the top wall or cap 28 and communicate with an interior volume 57 of container 22. Introduction port 56 can also include a luer connector or an internal taper wall 58 that can interconnect with an introduction syringe 60. A cap or plug 62 can be selectively interconnected with the introduction port 56, after a material is introduced into the container 22, to cap or block luer connector 58. Also defined through the top wall or cap 28 can be a second fraction or plasma withdrawal port 64 that can include a luer lock or connector 65 and also be selectively capped or blocked with a cap or plug 66. The second fraction or plasma withdrawal port 64 can be connected with a port or bore defined through the cap 28 to withdraw or remove a material that is positioned within volume 57 between the buoy system 30 and the cap 28 at any selected time, such as after a separation step formed with the separation system 20.
With reference to
The legs 70 can be formed in any appropriate configuration or number, including two legs as illustrated in
The annular member 72 can connect to spokes or extension members 76 extending radially from a central post or tube 78. The spokes 76 extend generally perpendicular to the axis A. The spokes, however, can extend at an angle relative to the central axis A for reduced drag, etc. The tube 78 defines an internal bore 80 that can communicate with a passage or internal bore 82 of the withdrawal port 50 to permit removal of material from the collection volume 40 of the buoy system 30. The central tube 78 includes an external wall 84 that extends axially from radial spokes 76 at a center or middle of the annular ring 72 to contact the lower buoy portion 44.
A connecting or fusion portion 86 of the central post or tube 78 can extend into and be fixed to the lower buoy portion 44 in an internal well or bore 90. The connecting portion 86 of the post 78 can be adhered, molded, fused, snap fitted, press fitted or interference fitted with the second buoy portion 44. The connection portion 86 can hold the first buoy portion 42 to the second buoy portion 44. Accordingly, the central post 78 can also assist legs 70 in holding the annular ring 72 a distance from the lower buoy portion 44 to define the collection volume 40. Alternatively, central post 78 can hold the annular ring 72 spaced from lower buoy portion 44 in the absence of legs 70.
Fins or raised portions 92 can extend upwardly from the surface 74 of the lower buoy portion 44. The fins 92 can include a ridge or notched portion 94. The central post 78 also can be fixed to the fins 92 to assist in fixing or holding the first buoy portion 42 a selected distance from the second buoy portion 44.
Lower buoy portion 44 can include upper surface 74, an annular or exterior wall 102 and a lower surface 45. The upper surface 74 of the lower buoy portion 44 can be conical and angled or inclined downwardly and inwardly from an outer circumferential edge 100 defined by the intersection or connection of the annular or exterior wall 102 and the upper surface 74. In an imaginary plane that includes longitudinal axis B of the central post 78 and that intersects the upper surface 74, axis B and the line of intersection of upper surface 74 subtend an angle α. The angle α can be any appropriate angle such as about 45° to about 90°, preferably about 75°. Alternatively, upper surface 74 can be concavely spherical rather than conical.
The central portion of the lower buoy portion 44 can define a sump or low portion 103 where a volume of material can be collected, as discussed further herein. The sump 103 can assist in forming a pellet of a selected portion of material, such as a cell fraction. The central post 78, which defines an axial bore 80, can also include a through passage that connects bore 80 in communication with an external receiving port 104 defined by outer wall 84 of post 78. The port 104 can be positioned in or at the bottom of the sump 103 to allow withdrawal of the collected material through the tube 78 and, in turn, through extraction port 50, withdrawal tube 46, and the withdraw port 48.
Positioned around the central post or tube 78 can be a valve system 110. The valve system 110 can include a sealing member 112 made of an appropriate material, such as a silicone rubber material. The sealing member 112 can be configured as a disc or washer including a central aperture, such as a round hole 113, to receive and fit around the central tube 78. A holding or valve actuation member 116 can include an upper apertured disc or washer 117 that is similar in surface area to the sealing member 112 and a mounting or holding cylinder or tube 118 that extends downwardly substantially perpendicularly from disc or washer 117. Holding cylinder 118 and washer 117 receive and fit around central tube 78 below sealing member 112. Holding cylinder 118 can also contact and be supported by the ledges 94 of fins 92 above surface 74, thereby leaving a circumferential clearance around tube 78 relative to fins 92 and holding cylinder 118 to provide communication among the wedge shaped spaces between fins 92. Briefly, the sealing member 112 and the disc 117 can form a flapper valve against the first buoy portion 42. The upper disc 117 of holding member 116 can bend to allow the sealing member 112 to move away from the first buoy portion 42, as discussed further herein and illustrated in
The height of the holding cylinder 118 can allow it to contact the ledge 94 and support the disc 117 at an appropriate elevation to hold the sealing member 112 against a bottom surface 120 of the annular member 72 when no opening force is acting on the valve portion 110. The spokes 76 can interconnect the annular member 72 with the central tube or post 78 but also form passages 122 (i.e. openings) between the spoke member 76. The passages 122, when opened by the valve system 110, allow material to move from an area above or exterior to the separation buoy system 30 into the collection volume 40.
The valve system 110 can be formed as one piece that includes both the sealing member 112 and the valve actuation member 116. For example, the sealing member 112 can be a flexible material, such as a silicone rubber, spread or applied to the disc 117 of the actuation portion 116. Alternatively, the sealing member 112 can be a separate piece that is fixed to the valve disc 117 with an adhesive or other connecting mechanism. Further, alternatively, the sealing member 112 can be separate from the valve actuation member 116 and only held in place with the biasing force of the valve actuation member 116. In other words, the sealing member 112 can be manufactured separate from the actuation member 116 or assembled together as the valve system 110.
The valve actuation member 116 can be formed of a material that can flex when a force is applied to it, such as a centrifugal force or pressure differential force, as discussed in detail herein. The material selected for the valve actuation member 116 can include acrylic, polycarbonate, and any other appropriate resilient and substantially inert material. The valve actuation member 116 can be formed of a resilient, yet flexible material. Thus, the actuation member 116 can also be referred to as a flexible member and provide a biasing or closing force on the sealing member 112 against the first buoy portion 42. The valve actuation member 116, therefore, can rebound from an open position to bias the valve 110 in the closed position.
The buoy system 30 can be made of any appropriate material and can be made of a material selected according to the biological material to be placed and separated in the separation system 20. The buoy system 30, however, can be made of materials having a mean density in the range of about 1.03 g/ml to about 1.10 g/ml, preferably in the range of about 1.045 g/ml to about 1.07 g/ml. The density or specific gravity of the buoy separation system 30 can be selected to position the collection volume 40 at an area or position within the separation container 20 relative to the material positioned in the separation system 20. The specific gravity of the buoy system 40 can be selected to move to a selected interface of two or more fractions of a separated multiple component material during separation.
For example, the second buoy portion 44 can be made of a single material or multiple materials and the upper buoy portion 42 can also be made of a single material or multiple materials. The density can be selected by selecting appropriate portions of the materials from which each of the members is made. Selecting the density of the material from which each of the elements of buoy system 30 is made, together with selecting the relative volumes, locations and dimensions of the elements, can assist in achieving a selected placement of the buoy system 30 within the material. The materials can also be selected to be substantially non-reactive to the material being separated in the system 20.
With reference to
The whole tissue sample 140 positioned in the separation system 20 can be any appropriate whole tissue sample. For example, the whole tissue sample can include whole blood, bone marrow aspirate or a mixture of whole blood and bone marrow aspirate. The whole tissue sample can include that described in U.S. Pat. No. 7,374,678, incorporated herein by reference above. The whole tissue same 140 positioned within the separation system 20, however, can be separated into selected portions or fractions and selected fractions can be withdrawn from the separation system 20.
The separation system 20 can then be positioned in a centrifuge device 150, as illustrated in
As illustrated in
Initially, the valve system 110 can be bent by the centrifugal forces and movement of the whole tissue sample 140 towards the collection volume 40. Then the valve 110 can remain in the open position, bent, during centrifugation due to the density difference between the denser flexible material of discs 112 and 117 and the less dense biological material, such as plasma.
Also, as discussed above, the separation container 22 can flex outwardly, allowing the buoy system 30 to move within the container 22 during centrifugation. The buoy system 30, having the selected density or specific gravity, can move within the separation container 22 to a selected interface of appropriate materials or fractions of the whole sample 140 that is being separated by the centrifugal force. Due to the flex of the container 22 a space can form between the buoy system 30 and the interior wall 32. Thus, material can also move in the direction of Y′ around the buoys system 30. The lower buoy portion 44 can include a conical lower surface 45 to assist in movement of the buoy system 30 away from the lower wall 26.
As illustrated in
After the centrifugation has stopped, the valve system 110 can close or seal the collection volume 40 from the first fraction 140a. Accordingly, during extraction or removal of the second fraction 140b within the separation or collection volume 40, the first fraction 140a will not interfere or mix with the second fraction 140b. Because the valve system 110 can assist in maintaining a physical separation of the selected fraction or second fraction 140b from the other fractions, the separated material can be maintained substantially pure and have a high yield.
Once the separation has concluded, an extraction withdraw syringe or system 160 can be used to withdraw the material or selected fraction 140b from the separation volume 40 via the interconnection of the withdrawal port 48 via the tube 46, the extraction port 50, the central post or tube 78, and the withdrawal hole 104. Once the material is withdrawn from the separation system 20, a user 170, such as a surgeon, can apply the material to a patient 180 in any appropriate manner. For example, the extraction withdrawal syringe 160 can be fitted or interconnected with a needle 182 to allow injection of the selected fraction into the patient 180. The selected fraction 140b, as discussed above, can include undifferentiated and/or stromal cells that can be applied to the patient 180 for selected purposes, such as tissue re-growth, healing, or other appropriate purposes.
Thus, the separation system 20 can allow for an introduction of autologous cells to the patient 180. The whole tissue sample 140 can be withdrawn from the patient 180 with the delivery syringe 60 during a single operative procedure. The centrifuge system 150 can be positioned in an operating room or near an operating room for appropriately timed separation of the whole tissue sample to allow for extraction withdrawal of the selected fraction 140b.
The foregoing description of the embodiments has been provided for purposes of illustration and description. It is not intended to be exhaustive or to limit the invention. Individual elements or feature of a particular embodiment are generally not limited to that particular embodiment, but, where applicable, are interchangeable and can be used in a selected embodiment, even if not specifically shown or described. The same may also be varied in many ways. Such variations are not to be regarded as a departure from the invention, and all such modifications are intended to be included within the scope of the invention.
Number | Name | Date | Kind |
---|---|---|---|
280820 | Hickson et al. | Jul 1883 | A |
593333 | Park | Nov 1897 | A |
1468313 | Lux | Sep 1923 | A |
1593814 | Vogel | Jul 1926 | A |
2722257 | Lockhart | Nov 1955 | A |
3013557 | Pallotta | Dec 1961 | A |
3141846 | Laven, Jr. | Jul 1964 | A |
3159159 | Cohen | Dec 1964 | A |
3300051 | Mitchell | Jan 1967 | A |
3409165 | Creith | Nov 1968 | A |
3420374 | Umeda | Jan 1969 | A |
3441143 | Kudlaty | Apr 1969 | A |
3453364 | Flodin et al. | Jul 1969 | A |
3469369 | Helmke | Sep 1969 | A |
3508653 | Coleman | Apr 1970 | A |
3545671 | Ross | Dec 1970 | A |
3583627 | Wilson | Jun 1971 | A |
3596652 | Winkelman | Aug 1971 | A |
3647070 | Adler | Mar 1972 | A |
3654925 | Holderith | Apr 1972 | A |
3661265 | Greenspan | May 1972 | A |
3706305 | Berger et al. | Dec 1972 | A |
3706306 | Berger et al. | Dec 1972 | A |
3723244 | Breillatt, Jr. | Mar 1973 | A |
3741400 | Dick | Jun 1973 | A |
3779383 | Ayres | Dec 1973 | A |
3785549 | Latham, Jr. | Jan 1974 | A |
3814248 | Lawhead | Jun 1974 | A |
3849072 | Ayres | Nov 1974 | A |
3850369 | Bull et al. | Nov 1974 | A |
3879295 | Glover et al. | Apr 1975 | A |
3887466 | Ayres | Jun 1975 | A |
3894952 | Ayres | Jul 1975 | A |
3896733 | Rosenberg | Jul 1975 | A |
3897337 | Ayres | Jul 1975 | A |
3897343 | Ayres | Jul 1975 | A |
3909419 | Ayres | Sep 1975 | A |
3929646 | Adler | Dec 1975 | A |
3931010 | Ayres et al. | Jan 1976 | A |
3931018 | North, Jr. | Jan 1976 | A |
3935113 | Ayres | Jan 1976 | A |
3937211 | Merten | Feb 1976 | A |
3941699 | Ayres | Mar 1976 | A |
3945928 | Ayres | Mar 1976 | A |
3951801 | Ayres | Apr 1976 | A |
3957654 | Ayres | May 1976 | A |
3962085 | Liston et al. | Jun 1976 | A |
3965889 | Sachs | Jun 1976 | A |
3972812 | Gresl, Jr. | Aug 1976 | A |
3982691 | Schlutz | Sep 1976 | A |
4001122 | Griffin | Jan 1977 | A |
4020831 | Adler | May 1977 | A |
4046699 | Zine, Jr. | Sep 1977 | A |
4055501 | Cornell | Oct 1977 | A |
4059108 | Latham, Jr. | Nov 1977 | A |
4066549 | Oeser et al. | Jan 1978 | A |
4077396 | Wardlaw et al. | Mar 1978 | A |
4088582 | Murty et al. | May 1978 | A |
4146172 | Cullis et al. | Mar 1979 | A |
4152270 | Cornell | May 1979 | A |
4154690 | Ballies et al. | May 1979 | A |
4159896 | Levine et al. | Jul 1979 | A |
4187979 | Cullis et al. | Feb 1980 | A |
4189385 | Greenspan | Feb 1980 | A |
4203840 | Stoeppler et al. | May 1980 | A |
4204537 | Latham, Jr. | May 1980 | A |
4225580 | Rothman et al. | Sep 1980 | A |
4229298 | Bange | Oct 1980 | A |
4269718 | Persidsky | May 1981 | A |
4294707 | Ikeda et al. | Oct 1981 | A |
4298598 | Schwarz et al. | Nov 1981 | A |
4300717 | Latham, Jr. | Nov 1981 | A |
4303193 | Latham, Jr. | Dec 1981 | A |
4314823 | Rich, Jr. et al. | Feb 1982 | A |
4322298 | Persidsky | Mar 1982 | A |
4332351 | Kellogg et al. | Jun 1982 | A |
4362567 | Schwarz et al. | Dec 1982 | A |
4364832 | Ballies et al. | Dec 1982 | A |
4377572 | Schwarz et al. | Mar 1983 | A |
4379849 | Heimreid | Apr 1983 | A |
4411794 | Schwinn et al. | Oct 1983 | A |
4414976 | Schwarz et al. | Nov 1983 | A |
4416654 | Schoendorfer et al. | Nov 1983 | A |
4417981 | Nugent | Nov 1983 | A |
4424132 | Iriguchi | Jan 1984 | A |
4427650 | Stroetmann et al. | Jan 1984 | A |
4427651 | Stroetmann et al. | Jan 1984 | A |
4442655 | Stroetmann et al. | Apr 1984 | A |
4443345 | Wells | Apr 1984 | A |
4445550 | Davis et al. | May 1984 | A |
4446021 | Aufderhaar et al. | May 1984 | A |
4453927 | Sinko | Jun 1984 | A |
4453939 | Zimmerman et al. | Jun 1984 | A |
4464167 | Schoendorfer et al. | Aug 1984 | A |
4511662 | Baran et al. | Apr 1985 | A |
4537767 | Rothman et al. | Aug 1985 | A |
RE32089 | Blatt et al. | Mar 1986 | E |
4577514 | Bradley et al. | Mar 1986 | A |
4610656 | Mortensen | Sep 1986 | A |
4617009 | Ohlin et al. | Oct 1986 | A |
4627879 | Rose et al. | Dec 1986 | A |
4631055 | Redl et al. | Dec 1986 | A |
4632761 | Bowers et al. | Dec 1986 | A |
4639316 | Eldegheidy | Jan 1987 | A |
4650678 | Fuhge et al. | Mar 1987 | A |
4655211 | Sakamoto et al. | Apr 1987 | A |
4672969 | Dew | Jun 1987 | A |
4675117 | Neumann et al. | Jun 1987 | A |
4680025 | Kruger et al. | Jul 1987 | A |
4714457 | Alterbaum | Dec 1987 | A |
4722790 | Cawley et al. | Feb 1988 | A |
4724317 | Brown et al. | Feb 1988 | A |
4735616 | Eibl et al. | Apr 1988 | A |
4735726 | Duggins | Apr 1988 | A |
4738655 | Brimhall et al. | Apr 1988 | A |
4755300 | Fischel et al. | Jul 1988 | A |
4755301 | Bowers | Jul 1988 | A |
4770779 | Ichikawa et al. | Sep 1988 | A |
4776964 | Schoendorfer et al. | Oct 1988 | A |
4818291 | Iwatsuki et al. | Apr 1989 | A |
4818386 | Burns | Apr 1989 | A |
4828710 | Itoh et al. | May 1989 | A |
4832851 | Bowers et al. | May 1989 | A |
4834890 | Brown et al. | May 1989 | A |
4839058 | Cawley et al. | Jun 1989 | A |
4844818 | Smith | Jul 1989 | A |
4846780 | Galloway et al. | Jul 1989 | A |
4846835 | Grande | Jul 1989 | A |
4850952 | Figdor et al. | Jul 1989 | A |
4853137 | Ersson | Aug 1989 | A |
4871462 | Fischel et al. | Oct 1989 | A |
4874368 | Miller et al. | Oct 1989 | A |
4877520 | Burns | Oct 1989 | A |
4879031 | Panzani | Nov 1989 | A |
4900453 | Sedlmayer et al. | Feb 1990 | A |
4902281 | Avoy | Feb 1990 | A |
4909251 | Seelich | Mar 1990 | A |
4915847 | Dillon et al. | Apr 1990 | A |
4917801 | Luderer et al. | Apr 1990 | A |
4928603 | Rose et al. | May 1990 | A |
4929242 | Desecki et al. | May 1990 | A |
4933291 | Daiss et al. | Jun 1990 | A |
4939081 | Figdor et al. | Jul 1990 | A |
4943273 | Pages | Jul 1990 | A |
4946601 | Fiehler | Aug 1990 | A |
4950220 | Wells et al. | Aug 1990 | A |
4957637 | Cornell | Sep 1990 | A |
4957638 | Smith | Sep 1990 | A |
4973168 | Chan | Nov 1990 | A |
4983157 | Pober et al. | Jan 1991 | A |
4983158 | Headley | Jan 1991 | A |
4985153 | Kuroda et al. | Jan 1991 | A |
5000970 | Shanbhag et al. | Mar 1991 | A |
5002571 | O'Donnell, Jr. et al. | Mar 1991 | A |
5019243 | McEwen et al. | May 1991 | A |
5024613 | Vasconcellos et al. | Jun 1991 | A |
5030215 | Morse et al. | Jul 1991 | A |
5030341 | McEwen et al. | Jul 1991 | A |
5039401 | Columbus et al. | Aug 1991 | A |
5045048 | Kaleskas et al. | Sep 1991 | A |
5047004 | Wells | Sep 1991 | A |
5053127 | Schoendorfer et al. | Oct 1991 | A |
5053134 | Luderer et al. | Oct 1991 | A |
5071570 | Shiraki et al. | Dec 1991 | A |
5080262 | Herold et al. | Jan 1992 | A |
5086784 | Levine et al. | Feb 1992 | A |
5100564 | Pall et al. | Mar 1992 | A |
5104375 | Wolf et al. | Apr 1992 | A |
5112484 | Zuk, Jr. | May 1992 | A |
5112490 | Turpen | May 1992 | A |
5131907 | Williams et al. | Jul 1992 | A |
5137832 | Levine et al. | Aug 1992 | A |
5141645 | Shiraki et al. | Aug 1992 | A |
5147290 | Jonsson | Sep 1992 | A |
5152905 | Pall et al. | Oct 1992 | A |
5156613 | Sawyer | Oct 1992 | A |
5165938 | Knighton | Nov 1992 | A |
5171456 | Hwang et al. | Dec 1992 | A |
5173295 | Wehling et al. | Dec 1992 | A |
5178602 | Wells | Jan 1993 | A |
5185001 | Galanakis | Feb 1993 | A |
5188583 | Guigan et al. | Feb 1993 | A |
5190057 | Sarfarazi | Mar 1993 | A |
5190759 | Lindblad et al. | Mar 1993 | A |
5197985 | Caplan et al. | Mar 1993 | A |
5203825 | Haynes et al. | Apr 1993 | A |
5204537 | Bennet et al. | Apr 1993 | A |
5206023 | Hunziker et al. | Apr 1993 | A |
5207638 | Choksi et al. | May 1993 | A |
5217426 | Bacehowski et al. | Jun 1993 | A |
5217627 | Pall et al. | Jun 1993 | A |
5219328 | Morse et al. | Jun 1993 | A |
5226877 | Epstein | Jul 1993 | A |
5226914 | Caplan et al. | Jul 1993 | A |
5234608 | Duff | Aug 1993 | A |
5236604 | Fiehler | Aug 1993 | A |
5251786 | Sarrine | Oct 1993 | A |
5258126 | Pall et al. | Nov 1993 | A |
5260420 | Burnouf-Radosevich et al. | Nov 1993 | A |
5269927 | Fiehler | Dec 1993 | A |
5271852 | Luoma, II | Dec 1993 | A |
5279825 | Wehling et al. | Jan 1994 | A |
5281342 | Biesel et al. | Jan 1994 | A |
5290552 | Sierra et al. | Mar 1994 | A |
5290918 | Bui-Khac et al. | Mar 1994 | A |
5298171 | Biesel et al. | Mar 1994 | A |
5304372 | Michalski et al. | Apr 1994 | A |
5316674 | Pall et al. | May 1994 | A |
5318524 | Morse et al. | Jun 1994 | A |
5318782 | Weis-Fogh et al. | Jun 1994 | A |
5321126 | van Dommelen et al. | Jun 1994 | A |
5322620 | Brown et al. | Jun 1994 | A |
5330974 | Pines et al. | Jul 1994 | A |
5344752 | Murphy | Sep 1994 | A |
5354483 | Furse | Oct 1994 | A |
5370221 | Magnusson et al. | Dec 1994 | A |
5370802 | Brown | Dec 1994 | A |
5372945 | Alchas et al. | Dec 1994 | A |
5376263 | Fischel | Dec 1994 | A |
5387187 | Fell et al. | Feb 1995 | A |
5393674 | Levine et al. | Feb 1995 | A |
5395923 | Bui-Khac et al. | Mar 1995 | A |
5403272 | Deniega et al. | Apr 1995 | A |
5405607 | Epstein | Apr 1995 | A |
5409833 | Hu et al. | Apr 1995 | A |
5411885 | Marx | May 1995 | A |
5417650 | Gordon | May 1995 | A |
5420250 | Lontz | May 1995 | A |
5443481 | Lee | Aug 1995 | A |
5454958 | Fiehler | Oct 1995 | A |
5456693 | Conston et al. | Oct 1995 | A |
5456885 | Coleman et al. | Oct 1995 | A |
5474687 | Van Vlasselaer | Dec 1995 | A |
5480378 | Weis-Fogh et al. | Jan 1996 | A |
5484383 | Fitch, Jr. et al. | Jan 1996 | A |
5486359 | Caplan et al. | Jan 1996 | A |
5494578 | Brown et al. | Feb 1996 | A |
5494592 | Latham, Jr. et al. | Feb 1996 | A |
5501371 | Schwartz-Feldman | Mar 1996 | A |
5505685 | Antwiler | Apr 1996 | A |
5510102 | Cochrum | Apr 1996 | A |
5520885 | Coelho et al. | May 1996 | A |
5525477 | Hassouna | Jun 1996 | A |
5533518 | Vogler | Jul 1996 | A |
5560830 | Coleman et al. | Oct 1996 | A |
5575778 | Hardt et al. | Nov 1996 | A |
5577513 | Van Vlasselaer | Nov 1996 | A |
5585007 | Antanavich et al. | Dec 1996 | A |
5588958 | Cunningham et al. | Dec 1996 | A |
5589462 | Patat et al. | Dec 1996 | A |
5601711 | Sklar et al. | Feb 1997 | A |
5601727 | Bormann et al. | Feb 1997 | A |
5603845 | Holm | Feb 1997 | A |
5607579 | Latham, Jr. et al. | Mar 1997 | A |
5614106 | Payrat et al. | Mar 1997 | A |
5618663 | Delmas et al. | Apr 1997 | A |
5632895 | Tsukagoshi et al. | May 1997 | A |
5632905 | Haynes | May 1997 | A |
5641414 | Brown | Jun 1997 | A |
5641622 | Lake et al. | Jun 1997 | A |
5643192 | Hirsh et al. | Jul 1997 | A |
5643193 | Papillon et al. | Jul 1997 | A |
5645540 | Henniges et al. | Jul 1997 | A |
5646004 | Van Vlasselaer | Jul 1997 | A |
5648223 | Van Vlasselaer | Jul 1997 | A |
5649903 | Deniega et al. | Jul 1997 | A |
5663051 | Vlasselaer | Sep 1997 | A |
5674173 | Hlavinka et al. | Oct 1997 | A |
5707331 | Wells et al. | Jan 1998 | A |
5707647 | Dunn et al. | Jan 1998 | A |
5707876 | Levine | Jan 1998 | A |
5716616 | Prockop et al. | Feb 1998 | A |
5723331 | Tubo et al. | Mar 1998 | A |
5724988 | Dennehey et al. | Mar 1998 | A |
5733466 | Benebo et al. | Mar 1998 | A |
5733545 | Hood, III | Mar 1998 | A |
5736033 | Coleman et al. | Apr 1998 | A |
5738784 | Holm et al. | Apr 1998 | A |
5738796 | Bormann et al. | Apr 1998 | A |
5750025 | Holmes et al. | May 1998 | A |
5750658 | Coelho et al. | May 1998 | A |
5762798 | Wenthold et al. | Jun 1998 | A |
5785700 | Olson | Jul 1998 | A |
5786217 | Tubo et al. | Jul 1998 | A |
5788662 | Antanavich et al. | Aug 1998 | A |
5792344 | Holm | Aug 1998 | A |
5795489 | Holm et al. | Aug 1998 | A |
5795571 | Cederholm-Williams et al. | Aug 1998 | A |
5795751 | Apel | Aug 1998 | A |
5811094 | Caplan et al. | Sep 1998 | A |
5811151 | Hendriks et al. | Sep 1998 | A |
5817519 | Zelmanovic et al. | Oct 1998 | A |
5823986 | Peterson | Oct 1998 | A |
5824084 | Muschler | Oct 1998 | A |
5830359 | Knight et al. | Nov 1998 | A |
5833866 | Brown | Nov 1998 | A |
5834418 | Brazeau et al. | Nov 1998 | A |
5837150 | Langley et al. | Nov 1998 | A |
5840502 | Van Vlasselaer | Nov 1998 | A |
5853600 | McNeal et al. | Dec 1998 | A |
5860937 | Cohen | Jan 1999 | A |
5863892 | Stern et al. | Jan 1999 | A |
5865785 | Bischof | Feb 1999 | A |
5885239 | Headley et al. | Mar 1999 | A |
5889584 | Wardlaw | Mar 1999 | A |
5895346 | Wells et al. | Apr 1999 | A |
5899874 | Jonsson et al. | May 1999 | A |
5900245 | Sawhney et al. | May 1999 | A |
5906934 | Grande et al. | May 1999 | A |
5916557 | Berlowitz-Tarrant et al. | Jun 1999 | A |
5916743 | Lake et al. | Jun 1999 | A |
5918622 | Perez et al. | Jul 1999 | A |
5924972 | Turvaville et al. | Jul 1999 | A |
5934803 | Hutter | Aug 1999 | A |
5938621 | Kelly et al. | Aug 1999 | A |
5951160 | Ronk | Sep 1999 | A |
5955032 | Kelly et al. | Sep 1999 | A |
5955436 | Kunkle, Jr. | Sep 1999 | A |
5958250 | Brown et al. | Sep 1999 | A |
5958253 | Holm et al. | Sep 1999 | A |
5961210 | McCardel et al. | Oct 1999 | A |
5980734 | Itoh et al. | Nov 1999 | A |
5980757 | Brown et al. | Nov 1999 | A |
5985315 | Patat et al. | Nov 1999 | A |
5997544 | Nies et al. | Dec 1999 | A |
6007811 | Sawyer et al. | Dec 1999 | A |
6010627 | Hood, III | Jan 2000 | A |
6011490 | Tonnesen et al. | Jan 2000 | A |
6020196 | Hu et al. | Feb 2000 | A |
6022306 | Dumont et al. | Feb 2000 | A |
6025201 | Zelmanovic et al. | Feb 2000 | A |
6027655 | Holm | Feb 2000 | A |
6049026 | Muschler | Apr 2000 | A |
6051146 | Green et al. | Apr 2000 | A |
6051147 | Bischof | Apr 2000 | A |
6053856 | Hlavinka | Apr 2000 | A |
6054122 | MacPhee et al. | Apr 2000 | A |
6063297 | Antanavich et al. | May 2000 | A |
6063624 | Kandler et al. | May 2000 | A |
6071421 | Brown | Jun 2000 | A |
6071422 | Hlavinka et al. | Jun 2000 | A |
6071423 | Brown et al. | Jun 2000 | A |
6090793 | Zimmermann et al. | Jul 2000 | A |
6096309 | Prior et al. | Aug 2000 | A |
6102843 | Kelley et al. | Aug 2000 | A |
6117425 | MacPhee et al. | Sep 2000 | A |
6123655 | Fell et al. | Sep 2000 | A |
6150163 | McPherson et al. | Nov 2000 | A |
6153113 | Goodrich et al. | Nov 2000 | A |
6183737 | Zaleske et al. | Feb 2001 | B1 |
6196987 | Holmes et al. | Mar 2001 | B1 |
6197325 | MacPhee et al. | Mar 2001 | B1 |
6200287 | Keller et al. | Mar 2001 | B1 |
6200606 | Peterson et al. | Mar 2001 | B1 |
6214338 | Antanavich et al. | Apr 2001 | B1 |
6221315 | Giesler et al. | Apr 2001 | B1 |
6245900 | Yamasaki et al. | Jun 2001 | B1 |
6264890 | Boehringer et al. | Jul 2001 | B1 |
6274090 | Coelho et al. | Aug 2001 | B1 |
6277961 | Hock et al. | Aug 2001 | B1 |
6280400 | Niermann | Aug 2001 | B1 |
6286670 | Smith | Sep 2001 | B1 |
6296602 | Headley | Oct 2001 | B1 |
6316247 | Katz et al. | Nov 2001 | B1 |
6322785 | Landesberg et al. | Nov 2001 | B1 |
6327491 | Franklin et al. | Dec 2001 | B1 |
6328765 | Hardwick et al. | Dec 2001 | B1 |
6334842 | Hlavinka et al. | Jan 2002 | B1 |
6342157 | Hood, III | Jan 2002 | B1 |
6351659 | Vilsmeier | Feb 2002 | B1 |
6355239 | Bruder et al. | Mar 2002 | B1 |
6368298 | Beretta et al. | Apr 2002 | B1 |
6368498 | Guilmette | Apr 2002 | B1 |
6398972 | Blasetti et al. | Jun 2002 | B1 |
6406671 | DiCesare et al. | Jun 2002 | B1 |
6409528 | Bodnar | Jun 2002 | B1 |
6410344 | Chung et al. | Jun 2002 | B1 |
6417004 | Brady et al. | Jul 2002 | B1 |
6440444 | Boyce et al. | Aug 2002 | B2 |
6444228 | Baugh et al. | Sep 2002 | B1 |
6464624 | Pages | Oct 2002 | B2 |
6471069 | Lin et al. | Oct 2002 | B2 |
6472162 | Coelho et al. | Oct 2002 | B1 |
6487992 | Hollis | Dec 2002 | B1 |
6508778 | Verkaart et al. | Jan 2003 | B1 |
6516953 | DiCesare et al. | Feb 2003 | B1 |
6523698 | Dennehey et al. | Feb 2003 | B1 |
6544162 | Van Wie et al. | Apr 2003 | B1 |
6544727 | Hei | Apr 2003 | B1 |
6558341 | Swisher | May 2003 | B1 |
6563953 | Lin et al. | May 2003 | B2 |
6596180 | Baugh et al. | Jul 2003 | B2 |
6623959 | Harris | Sep 2003 | B2 |
6629919 | Egozy et al. | Oct 2003 | B2 |
6638503 | Chitte et al. | Oct 2003 | B2 |
6676629 | Andrew et al. | Jan 2004 | B2 |
6716187 | Berckmans, III et al. | Apr 2004 | B1 |
6719901 | Dolecek et al. | Apr 2004 | B2 |
6733471 | Ericson et al. | May 2004 | B1 |
6758978 | Bedell | Jul 2004 | B1 |
6764531 | Hogan | Jul 2004 | B2 |
6777231 | Katz et al. | Aug 2004 | B1 |
6803022 | DiCesare et al. | Oct 2004 | B2 |
6811777 | Mishra | Nov 2004 | B2 |
6830762 | Baugh et al. | Dec 2004 | B2 |
6835353 | Smith et al. | Dec 2004 | B2 |
6835377 | Goldberg et al. | Dec 2004 | B2 |
RE38730 | Wells et al. | Apr 2005 | E |
6899813 | Dolecek et al. | May 2005 | B2 |
6905612 | Dorian et al. | Jun 2005 | B2 |
6911202 | Amir et al. | Jun 2005 | B2 |
RE38757 | Wells et al. | Jul 2005 | E |
6979307 | Beretta et al. | Dec 2005 | B2 |
7011644 | Andrew et al. | Mar 2006 | B1 |
7077273 | Ellsworth et al. | Jul 2006 | B2 |
7077827 | Greenfield | Jul 2006 | B2 |
7155288 | Soykan et al. | Dec 2006 | B2 |
7179391 | Leach et al. | Feb 2007 | B2 |
7195606 | Ballin | Mar 2007 | B2 |
7223346 | Dorian et al. | May 2007 | B2 |
7273886 | Olivero et al. | Sep 2007 | B2 |
7354515 | Coull et al. | Apr 2008 | B2 |
7374678 | Leach et al. | May 2008 | B2 |
7411006 | Shanbrom | Aug 2008 | B2 |
7470371 | Dorian et al. | Dec 2008 | B2 |
7531355 | Rodriguez et al. | May 2009 | B2 |
7553413 | Dorian et al. | Jun 2009 | B2 |
7694828 | Swift et al. | Apr 2010 | B2 |
7806276 | Leach et al. | Oct 2010 | B2 |
7845499 | Higgins et al. | Dec 2010 | B2 |
7901584 | Dorian et al. | Mar 2011 | B2 |
7914689 | Higgins et al. | Mar 2011 | B2 |
7987995 | Dorian et al. | Aug 2011 | B2 |
8048321 | Leach et al. | Nov 2011 | B2 |
8062534 | Higgins et al. | Nov 2011 | B2 |
8067534 | Jagota et al. | Nov 2011 | B2 |
8567609 | Landrigan et al. | Oct 2013 | B2 |
8596470 | Leach et al. | Dec 2013 | B2 |
8783470 | Hecker et al. | Jul 2014 | B2 |
8801586 | Dorian et al. | Aug 2014 | B2 |
8808551 | Leach et al. | Aug 2014 | B2 |
20010009757 | Bischof et al. | Jul 2001 | A1 |
20020032112 | Pages | Mar 2002 | A1 |
20020035820 | Farris | Mar 2002 | A1 |
20020076400 | Katz et al. | Jun 2002 | A1 |
20020082220 | Hoemann et al. | Jun 2002 | A1 |
20020090711 | Karlsson | Jul 2002 | A1 |
20020104808 | Blasetti et al. | Aug 2002 | A1 |
20020114775 | Pathak | Aug 2002 | A1 |
20020161449 | Muschler | Oct 2002 | A1 |
20020169408 | Beretta et al. | Nov 2002 | A1 |
20020172666 | Sacchi et al. | Nov 2002 | A1 |
20020182664 | Dolecek et al. | Dec 2002 | A1 |
20020192632 | Hei et al. | Dec 2002 | A1 |
20030033021 | Plouhar et al. | Feb 2003 | A1 |
20030033022 | Plouhar et al. | Feb 2003 | A1 |
20030050709 | Noth et al. | Mar 2003 | A1 |
20030050710 | Petersen et al. | Mar 2003 | A1 |
20030082152 | Hedrick et al. | May 2003 | A1 |
20030185803 | Kadiyala et al. | Oct 2003 | A1 |
20030191429 | Andrew et al. | Oct 2003 | A1 |
20030205538 | Dorian et al. | Nov 2003 | A1 |
20040005246 | Efthimiadis et al. | Jan 2004 | A1 |
20040013575 | Stevens et al. | Jan 2004 | A1 |
20040120942 | McGinnis et al. | Jun 2004 | A1 |
20040171146 | Katz et al. | Sep 2004 | A1 |
20040182395 | Brookman | Sep 2004 | A1 |
20040182788 | Dorian et al. | Sep 2004 | A1 |
20040182795 | Dorian et al. | Sep 2004 | A1 |
20040251217 | Leach et al. | Dec 2004 | A1 |
20050076396 | Katz et al. | Apr 2005 | A1 |
20050084961 | Hedrick et al. | Apr 2005 | A1 |
20050084962 | Simon | Apr 2005 | A1 |
20050109716 | Leach et al. | May 2005 | A1 |
20050130301 | McKay et al. | Jun 2005 | A1 |
20050145187 | Gray | Jul 2005 | A1 |
20050153441 | Hedrick et al. | Jul 2005 | A1 |
20050153442 | Katz et al. | Jul 2005 | A1 |
20050186120 | Dorian et al. | Aug 2005 | A1 |
20050196393 | Shanbrom | Sep 2005 | A1 |
20050196874 | Dorian et al. | Sep 2005 | A1 |
20050247715 | Ellsworth et al. | Nov 2005 | A1 |
20050260174 | Fraser et al. | Nov 2005 | A1 |
20050260175 | Hedrick et al. | Nov 2005 | A1 |
20050282275 | Katz et al. | Dec 2005 | A1 |
20060051865 | Higgins et al. | Mar 2006 | A1 |
20060057693 | Simon | Mar 2006 | A1 |
20060083720 | Fraser et al. | Apr 2006 | A1 |
20060140923 | Evangelista et al. | Jun 2006 | A1 |
20060151384 | Ellsworth et al. | Jul 2006 | A1 |
20060175242 | Dorian et al. | Aug 2006 | A1 |
20060175244 | Dorian et al. | Aug 2006 | A1 |
20060178610 | Nowakowski | Aug 2006 | A1 |
20060196885 | Leach et al. | Sep 2006 | A1 |
20060243676 | Swift et al. | Nov 2006 | A1 |
20060273049 | Leach et al. | Dec 2006 | A1 |
20060273050 | Higgins et al. | Dec 2006 | A1 |
20060278588 | Woodell-May | Dec 2006 | A1 |
20070034579 | Dorian et al. | Feb 2007 | A1 |
20070036768 | Fraser et al. | Feb 2007 | A1 |
20070075016 | Leach | Apr 2007 | A1 |
20070208321 | Leach et al. | Sep 2007 | A1 |
20080011684 | Dorian et al. | Jan 2008 | A1 |
20080164204 | Hatamian et al. | Jul 2008 | A1 |
20080173593 | Coull et al. | Jul 2008 | A1 |
20080193424 | McKale et al. | Aug 2008 | A1 |
20080210645 | Coull et al. | Sep 2008 | A1 |
20080217263 | Higgins et al. | Sep 2008 | A1 |
20080217264 | Leach et al. | Sep 2008 | A1 |
20080217265 | Leach et al. | Sep 2008 | A1 |
20080268064 | Woodell-May | Oct 2008 | A1 |
20080269762 | Simon et al. | Oct 2008 | A1 |
20080283474 | Leach et al. | Nov 2008 | A1 |
20080306431 | Yoo | Dec 2008 | A1 |
20080318317 | Roche et al. | Dec 2008 | A1 |
20090014391 | Leach et al. | Jan 2009 | A1 |
20090018313 | Shanbrom | Jan 2009 | A1 |
20090101599 | Dorian et al. | Apr 2009 | A1 |
20090192528 | Higgins et al. | Jul 2009 | A1 |
20090220482 | Higgins et al. | Sep 2009 | A1 |
20090221075 | Dorian et al. | Sep 2009 | A1 |
20090236297 | Dorian et al. | Sep 2009 | A1 |
20090250413 | Hoeppner | Oct 2009 | A1 |
20090253566 | Chavarria | Oct 2009 | A1 |
20090289014 | Hoeppner | Nov 2009 | A1 |
20100055087 | Higgins et al. | Mar 2010 | A1 |
20100140182 | Chapman et al. | Jun 2010 | A1 |
20100186676 | Van Der Berg | Jul 2010 | A1 |
20100206798 | Dorian et al. | Aug 2010 | A1 |
20100256595 | Leach et al. | Oct 2010 | A1 |
20100323870 | Leach et al. | Dec 2010 | A1 |
20100324450 | Leach et al. | Dec 2010 | A1 |
20110020196 | Grippi et al. | Jan 2011 | A1 |
20110021334 | Leach et al. | Jan 2011 | A1 |
20110036786 | Ellsworth | Feb 2011 | A1 |
20110056893 | Leach et al. | Mar 2011 | A1 |
20110065183 | Dorian et al. | Mar 2011 | A1 |
20110077596 | Higgins et al. | Mar 2011 | A1 |
20110168193 | Leach et al. | Jul 2011 | A1 |
20110192804 | Landrigan et al. | Aug 2011 | A1 |
20110251041 | Chavarria et al. | Oct 2011 | A1 |
20140051061 | Landrigan et al. | Feb 2014 | A1 |
20140054246 | Landrigan et al. | Feb 2014 | A1 |
20140091048 | Leach et al. | Apr 2014 | A1 |
20140275497 | Leach et al. | Sep 2014 | A1 |
20140349388 | Dorian et al. | Nov 2014 | A1 |
20140356446 | Leach et al. | Dec 2014 | A1 |
Number | Date | Country |
---|---|---|
696278 | Jan 1999 | AU |
9103724 | Mar 1993 | BR |
1321138 | Aug 1993 | CA |
2182862 | Jun 1996 | CA |
2448415 | Dec 2002 | CA |
2448415 | Dec 2002 | CA |
1074709 | Jul 1993 | CN |
1321103 | Nov 2001 | CN |
1322146 | Nov 2001 | CN |
103702729 | Apr 2014 | CN |
56103 | Oct 1860 | DE |
56103 | Oct 1860 | DE |
1443359 | Nov 1968 | DE |
4202667 | May 1993 | DE |
090997 | Oct 1983 | EP |
0102773 | Mar 1984 | EP |
0109374 | May 1984 | EP |
0142339 | May 1985 | EP |
0244834 | Nov 1987 | EP |
0244834 | Nov 1987 | EP |
0253198 | Jan 1988 | EP |
0295771 | Dec 1988 | EP |
0417818 | Mar 1991 | EP |
0534178 | Mar 1993 | EP |
534178 | Mar 1993 | EP |
0592242 | Apr 1994 | EP |
1005910 | Jun 2000 | EP |
1006360 | Jun 2000 | EP |
1006360 | Jun 2000 | EP |
1289618 | Mar 2003 | EP |
1406492 | Apr 2004 | EP |
1406492 | Apr 2004 | EP |
1427279 | Jun 2004 | EP |
1427279 | Jun 2004 | EP |
1467746 | Oct 2004 | EP |
1467746 | Oct 2004 | EP |
1509326 | Mar 2005 | EP |
1670315 | Jun 2006 | EP |
1670315 | Jun 2006 | EP |
1716901 | Nov 2006 | EP |
854715 | Nov 1960 | GB |
60-053845 | Mar 1985 | JP |
60250014 | Dec 1985 | JP |
60250014 | Dec 1985 | JP |
2036872 | Feb 1990 | JP |
02071747 | Mar 1990 | JP |
2000199760 | Jul 2000 | JP |
02129224 | Oct 2000 | JP |
2004-305439 | Nov 2004 | JP |
2005013783 | Jan 2005 | JP |
200598704 | Apr 2005 | JP |
2005524451 | Aug 2005 | JP |
2006-305365 | Nov 2006 | JP |
2006527025 | Nov 2006 | JP |
2008104789 | May 2008 | JP |
8400905 | Mar 1984 | WO |
WO-8400905 | Mar 1984 | WO |
8802259 | Apr 1988 | WO |
WO-8802259 | Apr 1988 | WO |
9010031 | Sep 1990 | WO |
WO-9010031 | Sep 1990 | WO |
9222312 | Dec 1992 | WO |
WO-9222312 | Dec 1992 | WO |
9305067 | Mar 1993 | WO |
WO-9305067 | Mar 1993 | WO |
9308904 | May 1993 | WO |
WO-9308904 | May 1993 | WO |
9407548 | Apr 1994 | WO |
WO-9407548 | Apr 1994 | WO |
9617871 | Jun 1996 | WO |
9617871 | Jun 1996 | WO |
WO-9617871 | Jun 1996 | WO |
WO-9617871 | Jun 1996 | WO |
9848938 | Nov 1998 | WO |
WO-9848938 | Nov 1998 | WO |
0061256 | Oct 2000 | WO |
WO-0061256 | Oct 2000 | WO |
0074713 | Dec 2000 | WO |
WO-0074713 | Dec 2000 | WO |
0103756 | Jan 2001 | WO |
WO-0103756 | Jan 2001 | WO |
0183068 | Nov 2001 | WO |
WO-0183068 | Nov 2001 | WO |
0238610 | May 2002 | WO |
WO-0238610 | May 2002 | WO |
02060925 | Aug 2002 | WO |
WO-02060925 | Aug 2002 | WO |
02098566 | Dec 2002 | WO |
WO-02098566 | Dec 2002 | WO |
03015800 | Feb 2003 | WO |
WO-03015800 | Feb 2003 | WO |
03024215 | Mar 2003 | WO |
WO-03024215 | Mar 2003 | WO |
03053362 | Jul 2003 | WO |
WO-03053362 | Jul 2003 | WO |
03088905 | Oct 2003 | WO |
WO-03088905 | Oct 2003 | WO |
03092894 | Nov 2003 | WO |
WO-03092894 | Nov 2003 | WO |
03099412 | Dec 2003 | WO |
WO-03099412 | Dec 2003 | WO |
2004009207 | Jan 2004 | WO |
WO-2004009207 | Jan 2004 | WO |
2004104553 | Dec 2004 | WO |
WO-2004104553 | Dec 2004 | WO |
2005034843 | Apr 2005 | WO |
WO-2005034843 | Apr 2005 | WO |
WO-2006041406 | Apr 2006 | WO |
2007127834 | Nov 2007 | WO |
WO-2007127834 | Nov 2007 | WO |
2007142908 | Dec 2007 | WO |
WO-2007142908 | Dec 2007 | WO |
WO-2008127639 | Oct 2008 | WO |
2009021257 | Feb 2009 | WO |
WO-2009021257 | Feb 2009 | WO |
WO-2009111338 | Sep 2009 | WO |
WO-2011008836 | Jan 2011 | WO |
Entry |
---|
Clayden J D Et Al: “Improved segmentation reproducibility in group tractography using a quantitative tract similarity measure” Neuroimage, Academic Press, Orlando, FL, US LNKD-DOI: 10.1016/J.Neuroimage. 2006.07.016, vol. 33, No. 2, Nov. 1, 2006, pp. 482-492. |
De Wit, et al. “Experiments on the Preparation of Blood Components with the IBM 2991 Blood Cell Processor” Vox Sang. 29: 352-362 (Feb. 10, 1975). |
Ehricke H H Et Al: “Visualizing MR diffusion tensor fields by dynamic fiber tracking and uncertainty mapping” Computers and Graphics, Elsevvier, GB LNKD-DOI: 10.1016/J. Cag.2006.01.031, vol. 30, No. 2, Apr. 1, 2006, pp. 255-264. |
European Communication Pursuant to Article 94(3) EPC mailed May 6, 2013 for PCT/US2010/029957 which claims benefit of U.S. Appl. No. 12/417,789, filed Apr. 3, 2009. |
International Preliminary Report on Patentability and Written Opinion mailed Oct. 31, 2013 for PCT/US2012/034104 claiming benefit of U.S. Appl. No. 13/089,591, filed Apr. 19, 2011. |
International Search Report and Written Opinion mailed Dec. 5, 2013 for PCT/US2013/056793 claiming benefit of U.S. Appl. No. 13/595,461, filed Aug. 27, 2012. |
International Search Report for PCT/US2012/034104 mailed Oct. 29, 2012, claiming benefit of U.S. Appl. No. 13/089,591, filed Apr. 18, 2012. |
Invitation to Pay Additional Fees and, Where Applicable, Protest Fee mailed Aug. 6, 2012 for PCT/US2012/034104 claiming benefit of U.S. Appl. No. 13/089,591 filed Apr. 19, 2011. |
Japan Office Action mailed Aug. 23, 2013 for Japan Patent Application No. 2010-503066. |
Japan Office Action mailed Jan. 22, 2013 for Japan Application No. 2010-503066. |
Japanese Office Action mailed May 20, 2014 for Japanese Application No. JP2012-503768. |
Jones D K et al: “Confidence mapping in diffusion ensor magnetic resonance imaging tractography using a bootstrap approach” Magnetic Resonance in Medicine Wiley USA, vol. 53, No. 5, May 2005, pp. 1143-1149. |
Lori N F Et Al: “Diffusion tensor fiber tracking of human brain connectivity: acquisition methods, reliability analysis and biological results” NMR in Biomedicine Wiley UK, vol. 15, No. 7-8, Nov. 2002, pp. 493-515. |
Notice of Allowance mailed Mar. 24, 2011 for U.S. Appl. No. 12/101,586. |
Notice of Allowance mailed Oct. 18, 2011 for U.S. Appl. No. 12/897,401. |
Parchment et al., Roles for in vitro myelotoxicity tests in preclincial drug development and clinical trial planning, Toxicology Pathology, Society of Toxicological Pathologists, vol. 21, No. 2, 1993, pp. 241-250. |
Lerner, R. and N. S. Binur. “Current status of surgical adhesives.” J Surg Res 48 (Feb. 1990): 165-81. |
Matras, Helene, H. P. Dinges, H. Lassmann, and B. Mamoli. “Zur nahtlosen interfaszikularen Nerventransplantation im Tierexperiment.” Wein Med Woschtr 122:37 (1972): 517-523. |
Moretz, W., Jr., J Shea Jr., J. R. Emmett, and J Shea. “A simple autologous fibrinogen glue for otologic surgery.” Otolaryngol Head Neck Surg 95 (Jul. 1986): 122-4. |
Nakagami, Hironori, et al., “Novel Autologous Cell Therapy in Ischemic Limb Disease Through Growth Factor Secretion by Cultured Adipose Tissue-Derived Stromal Cells,” Angiogenesis by Adipose Tissue-Derived Cells, (Dec. 2005) pp. 2542-2547, American Heart Association, Inc. |
Nathan, Suresh,, et al., “Cell-Based Therapy in the Repair of Osteochondral Defects: A Novel Use for Adipose Tissue,” Tissue Engineering, vol. 9, No. 4 (2003) pp. 733-744 Mary Ann Liebert, Inc. |
Planat-Bénard, V., et al., “Spontaneous Cardiomyocyte Differentiation From Adipose Tissue Stroma Cells,” Adipose-Derived Cell Cardiomyocyte (Feb. 6, 2004) pp. 223-229 American Heart Association, Inc. |
Rubin, M.D., et al, “Clinical Treatment of Radiotherapy Tissue Damage by Lipoaspirate Transplant: A Healing Process Mediated by Adipose-Derived Adult Stem Cells,” Plastic and Reconstructive Surgery, Discussion vol. 119, No. 5, Stem Cell Therapy for Angiogenesis, (Apr. 15, 2007) pp. 1423-1424. |
Sanal, M. “Does fibrin glue cause foreign body reactions? [letter].” Eur J Pediatr Surg 3 (1992): 190 (1 page). |
Sanal, M., H. Dogruyol, A. Gurpinar, and O. Yerci. “Does fibrin glue cause foreign body reactions?” Eur—r J Pediatr Surg 2 (1992): 285-6. |
Schäffler, Andreas, et al., “Concise Review: Adipose Tissue-Derived Stromal Cells—Basic and Clinical Implications for Novel Cell-Based Therapies,” Tissue-Specific Stem Cells, Stem Cells® (Apr. 10, 2007) pp. 818-827 AlphaMed Press. |
Semple, Elizabeth, PhD, et al. “Quality of Thrombin Produced From the Patient's Own Plasma Using the TPD™ , a New Thrombin-Processing Device.” Journal of American Society of Extra-Corporeal Technology. JECT: 2005; 37:196-200. |
Sierra, D. H. “Fibrin sealant adhesive systems: a review of their chemistry, material properties and clinical applications.” J Biomater Appl 7 (Apr. 1993): 309-52. |
Takahashi, Kazutoshi et al., “Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors,” Cell, (Nov. 30, 2007) pp. 1-12, Elsevier Inc. |
The American Journal of Surgery, vol. 168, pp. 120-122, Aug. 1994, Roy L. Tawes, Jr., MD., et al., “Autologous Fibrin Glue: The Last Step in Operative Hemostatis”. |
Weis-Fogh, U. S. “Fibrinogen prepared from small blood samples for autologous use in a tissue adhesive system.” Eur Surg Res 20 (1988): 381-9. |
Wiseman, David M., David T. Rovee, and Oscar M. Alverez. “Wound Dressings: Design and Use.” In Wound Healing: Biochemical & Clinical Aspects,ed. I. Kelman Cohen, Robert F. Diegelmann, and William J. Lindblad. 562-580. 1st ed., Vol. Philadelphia: W. B. Saunders Company, 1992. |
Woodell-May, et al., “Producing Accurate Platelet Counts for Platelet Rich Plasma: Validation of a Hematology Analyzer and Preparation Techniques for Counting,” Scientific Foundation, Journal of Carniofacial Surgery 16 (5):749-756 (Sep. 2005). |
“Frequently Asked Questions, 1. Kits, 2. Enzymes,” (2003) 3 pages Worthington Biochemical Corp. |
“MarrowStim™ Concentration System,” brochure. Biomet Biologics Jun. 15, 2008. |
Berguer, R., R. L. Staerkel, E. E. Moore, F. A. Moore, W. B. Galloway, and M. B. Mockus. “Warning: fatal reaction to the use of fibrin glue in deep hepatic wounds. Case reports.” J Trauma 31:3 (1991): 408-11. |
Berruyer, M., J. Amiral, P. Ffrench, J. Belleville, O. Bastien, J. Clerc, A. Kassir, S. Estanove, and M. Dechavanne. “Immunization by bovine thrombin used with fibrin glue during cardiovascular operations. Development of thrombin and factor V inhibitors,” J Thorac Cardiovasc Surg 105: 5 (1993): 892-7. |
BioCUE™ Platelet Concentration System, Jun. 2010. (2 pages). |
Boomgaard, et al., “Pooled Platelet Concentrates Prepared by the Platelet-Rich-Plasma Method and Filtered with Three Different Filters and Stored for 8 Days.” Vox Sanq, vol. 68: 82-89, Feb. 1995. |
Brodke, et al., “Bone Grafts Prepared with Selective Cell Retention Technology Heal Canine Segmental Defects as Effectively as Autograft”, SCR-Enriched Bone Grafts Heal Canine Segmental Defects, Journal of Orthopaedic Research (May 2006) pp. 857-866. |
Casali, B., F. Rodeghiero, A. Tosetto, B. Palmieri, R. Immovilli, C. Ghedini, and P. Rivasi. “Fibrin glue from single-donation autologous plasmapheresis.” Transfusion 32:7 (1992): 641-3. |
Collier, B.S. et al., “The pH Dependence of Quantitative Ristocetin-induced Platelet Aggregation: Theoretical and Practical Implications—A New Device for Maintenance of Platelet-Rich Plasma pH”, Hematology Service, Clinical Pathology Department, Clinical Center, National Institutes of Health, Bethesda, Md. 20014, Blood, vol. 47, No. 5 (May 1976). |
Connolly, “Injectable Bone Marrow Preparations to Stimulate Osteogenic Repair,” Clinical Orthopaedics and Related Research 313:8-18 (Apr. 1995). |
DelRossi, A. J., A. C. Cernaianu, R. A.Vertrees, C. J. Wacker, S. J. Fuller, J. Cilley Jr., and W. A. Baldino. “Platelet-rich plasma reduces postoperative blood loss after cardiopulmonary bypass.” J Thorac Cardiovasc Surg 100:2 (Aug. 1990): 281-6. |
Edlich, Richard F., George T. Rodeheaver, and John G. Thacker. “Surgical Devices in Wound Healing Management.” In Wound Healing: Biochemical & Clinical Aspects,ed. I. Kelman Cohen, Robert F. Diegelmann, and William J. Lindblad. 581-600. 1st ed., Vol. Philadelphia: W.B. Saunders Company, 1992. |
Epstein, G. H., R. A. Weisman, S. Zwillenberg, and A. D. Schreiber. “A new autologous fibrinogen-based adhesive for otologic surgery.” Ann Otol Rhino Laryngol 95 (May 25-26, 1985) 40-5. |
First clinical results: Kuderma, H. and Helene Matras. “Die klinische Anwendung der Klebung van Nervenanastomosen mit Gerinnungssubstanzen bei der Rekonstruction verletzter peripherer Nerven.” Wein Klin Wochenschr 87 (Aug. 15, 1975): 495-501. |
Gibble, J. W. and P. M. Ness. “Fibrin glue: the perfect operative sealant?” Transfusion 30 (1990): 741-7. |
Gimble, Jeffrey M., “Adipose-Derived Stem Cells for Regenerative Medicine,” Circulation Research (May 11, 2007) pp. 1249-1260, American Heart Association, Inc. |
GPS® System, “GPS® Platelet Concentrate System,” Cell Factor Technologies, Inc., Biomet Orthopaedics, Inc., (Feb. 29, 2004) (9 pages). |
GPS® II System, Gravitational Platelet Separation System, “Accelerating the Body's Natural Healing Process,” Biomet Biologics (Jul. 15, 2006) 16 pages. |
GPS® II System, Gravitational Platelet Separation System, “Accelerating the Body's Natural Healing Process,” Cell Factor Technologies, Inc., Biomet Europe (2005) 16 pages, http://www.cellfactortech.com/global—products.cfm, printed Sep. 16, 2005. |
GPS® II System, Gravitational Platelet Separation System, “User Manual,” Cell Factor Technologies, Inc., Biomet Europe [date unknown] 13 pages, http://www.cellfactortech.com/global—products.cfm, printed Sep. 16, 2005. |
Hartman, A. R., D. K. Galanakis, M. P. Honig, F. C. Seifert, and C. E. Anagnostopoulos. “Autologous whole plasma fibrin gel. Intraoperative procurement.” Arch Surg 127 (Mar. 1992): 357-9. |
Harvest SmartPrep PRP-20 Procedure Pack, “Instructions for Use” (date unknown). |
Hennis, H. L., W. C. Stewart, and E. K. Jeter. “Infectious disease risks of fibrin glue [letter].” Ophthalmic Surg 23 (Sep. 1992): 640. |
Hom, D., et al. “Promoting Healing with Recombinant Human Platelet-Derived Growth Factor-BD in a Previously Irradiated Problem Wound.” The Laryngoscope, vol. 113 (pp. 1566-1671) Sep. 2003. |
International Search Report and Written Opinion mailed Jul. 3, 2009 for PCT/US2009/035564 claiming benefit of U.S. Appl. No. 61/078178, filed Jul. 3, 2008. |
Jackson, C. M. and Y. Nemerson. “Blood coagulation.” Annu Rev Biochem 49 (1980): 765-811). |
Johnstone, et al., “Autologous Mesenchymal Progenitor Cells in Articular Cartilage Repair”, Clinical Orthopaedics and Related Research 367S:S156-S162 (Oct. 1999). |
Journal of Oral Maxillofacial Surgery, vol. 43, pp. 605-611, Helene Matras, M.D., “Fibrin Seal: The State of the Art” (1985). |
Karpatkin, S., “Heterogeneity of Human Platelets. VI,, Correlation of Platelet Function with Platelet Volume”, Blood, vol. 51, No. 2 (Feb. 1978). |
Kjaergard, H. K., U. S. Weis-Fogh, H. Sorensen, J. Thiis, and I. Rygg. “A simple method of preparation of autologous fibrin glue by means of ethanol.” Surg Gynecol Obstet 175 (1992): 72-3. |
Kjaergard, H. K., Fogh Us Weis, and J. J. Thiis. “Preparation of autologous fibrin glue from pericardial blood.” Ann Thorac Sur 55 (1993): 543-4. |
Kumar, Vijay et al. “Stability of Human Thrombin Produced From 11 ml of Plasma Using the Thrombin Processing Device,” Journal of American Society of Extra-Corporeal Technology. JECT: Mar. 2005:37; 390-395. |
Kumar, Vijay et al. “Whole Blood Thrombin: Development of a Process for Intra-Operative Production of Human Thrombin.” Journal of American Society of Extra-Corporeal Technology. JECT: Apr. 2007; 39:18-23. |
Kumar, Vijay et al., “Autologous Thrombin: Intraoperative Production From Whole Blood.” Journal of American Society of Extra-Corporeal Technology. JECT: Apr. 2008; 40:94-98. |
Lasher, Lisa, M.D., “My Experience with PRP,” PowerPoint presentation, http:/Iwww.cellfactortech.com/global—products.cfm, printed Sep. 16, 2005. |
“MarrowStim™ Concentration Kit Peripheral Arterial Disease (PAD) Study” brochure. Web. Jul. 2, 2009 http://www.biomet.com/patients/clinical—recruitment—padstudy.cfm. |
“MarrowStimä Concentration System,” brochure. Biomet Biologics Jun. 15, 2008. |
International Search Report and Written Opinion mailed Oct. 8, 2010 for PCT/US2010/041942 claiming benefit of U.S. Appl. No. 12/504,413, filed Jul. 16, 2009. |
“Cell Isolation Techniques, Methods and Materials, Working with Enzymes,” (2004) (9 pages) Worthington Biochemical Corp. |
“Cell Isolation Theory, Tissue Types,” (2004) (5 pages) Worthington Biochemical Corp. |
“Clotalyst® Autologous Clotting Factor. Would you like to have an autologous thrombin for rapid clotting and haemostasis?” Brochure. Biomet Biologics (Aug. 15, 2008). |
“Cytori Celution Cell Concentrate Device,” Exhibit 14, 510(k) Summary, FDA approval K060482 (Sep. 28, 2006). |
“Frequently Asked Questions, 1. Kits, 2. Engzymes,” (2003) 3 pages Worthington Biochemical Corp. |
“ThermoGenesis Corp. to Supply Autologous Thrombin Kits to Biomet, Inc.,” PR Newslink: http:/tinyurl.com/4h3up. (Apr. 5, 2005) http://www.noblood.org/press-releases/2128-thermogenesis-corp-supply-autologous-thrombin-kits-biomet-inc [web accessed Sep. 27, 2011]. |
“Trypsinizing cells.” Bart's Cookbook, Web. Apr. 14, 2010. http://pingu.salk.edu/˜sefton/Hyper—protocols/trypsin.html. |
Anesthesiology, vol. 81, No. 4, pp. 1074-1077, Oct. 1994, Hiromasa Mitsuhata, M.D., et al., “An Anaphylactic Reaction to Topical Fibrin Glue”. |
Ann Thorac Surg, vol. 53, pp. 530-531, 1992, Mehmet C. Oz, M.D., et al., “Autologous Fibrin Glue From Intraoperatively Collected Platelet-Rich Plasma”. |
Ann Thorac Surg, vol. 56, pp. 387-389, 1993, Robert L. Quigley, M.D., et al., “Intraoperative Procurement of Autologous Fibrin Glue”. |
Badiavas, et al., “Treatment of Chronic Wounds With Bone Marrow-Derived Cells,” (Reprinted) Arch Dermatol. 139:510-516 (Apr. 2003). |
Bang, N.U., et al., “Plasma Protein Requirements for Human Platelet Aggregation” Ann. N.Y. Acad Sci, 201:280-299 (1972). |
Berguer, R., R. L. Staerkel, E. E. Moore, F. A. Moore, W. B. Galloway, and M. B. Mockus. “Warning: fatal reaction to the use of fibrin glue in deep hepatic wounds. Case reports.” J Trauma 31 (3 1991): 408-11. |
Berruyer, M., J. Amiral, P. Ffrench, J. Belleville, O. Bastien, J. Clerc, A. Kassir, S. Estanove, and M. Dechavanne. “Immunization by bovine thrombin used with fibrin glue during cardiovascular operations. Development of thrombin and factor V inhibitors,” J Thorac Cardiovasc Surg, 105 (5 1993): 892-7. |
BioCUE™ Platelet Concentration System, Dec. 2010. (2 pages). |
Biopolymers, vol. 27, pp. 763-774, 1988, Gerald Marx, “Mechanism of Fibrin Coagulation Based on Selective, Cation-Driven, Protofibral Association”. |
Brodke, et al., “Bone Grafts Prepared with Selective Cell Retention Technology Heal Canine Segmental Defects as Effectively as Autograft”, SCR-Enriched Bone Crafts Heal Canine Segmental Defects, Journal of Orthopaedic Research (May 2006) pp. 857-866. |
Casali, B., F. Rodeghiero, A. Tosetto, B. Palmieri, R. Immovilli, C. Ghedini, and P. Rivasi. “Fibrin glue from single-donation autologous plasmapheresis.” Transfusion 32 (7 1992): 641-3. |
CLOTALYST™ Automatic Clotting Factor, Would you like to have an autologous thrombin for rapid clotting and haemostasis?, brochure, Biomet Biologics, Inc., Feb. 2007 (12 pages). |
Collier, B.S. et al., “The pH Dependence of Quantitative Ristocetin-induced Platelet Aggregation: Theoretical and Practical Implications—A New Device for Maintenance of Platelet-Rich Plasma pH”, Hematology Service, Clinical Pathology Department, Clinical Center, National Institutes of Health, Bethesda, Md. 20014, Blood, vol. 47, No. 5 (May), 1976. |
Connolly, “Injectable Bone Marrow Preparations to Stimulate Osteogenic Repair,” Clinical Orthopaedics and Related Research 313:8-18 (1995). |
Connolly, John, M.D., et al. “Development of an Osteogenic Bone-Marrow Preparation.” The Journal of Bone and Joint Surgery, Incorporated. vol. 71-A, No. 5 (Jun. 1989) pp. 684-691. |
Dallari, et al., “In Vivo Study on the Healing of Bone Defects Treated with Bone Marrow Stromal Cells, Platelet-Rich Plasma, and Freeze-Dried Bone Allografts, Alone and in Combination,” Healing of Bone Defects, Journal of Orthopaedic Research (May 2006) pp. 877-888. |
De Ugarte, et al., “Comparison of Multi-Lineage Cells from Human Adipose Tissue and Bone Marrow,” Cells Tissues Organs 174:101-109 (2003). |
De Ugarte, et al., “Differential Expression of Stem Cell Mobilization-Associated Molecules on Multi-Lineage Cells from Adipose Tissue and Bone Marrow,” Immunology Letters 89:267-270 (2003). |
DelRossi, A. J., A. C. Cernaianu, R. A.Vertrees, C. J. Wacker, S. J. Fuller, J. Cilley Jr., and W. A. Baldino. “Platelet-rich plasma reduces postoperative blood loss after cardiopulmonary bypass.” J Thorac Cardiovasc Surg 100 (2 1990): 281-6. |
DePalma, L., et al., “The preparation of fibrinogen concentrate for use as fibrin glue by four different methods.” Transfusion (1993) vol. 33, No. 9; pp. 717-720. |
DeUgarte, M.D., Daniel A., et al., “Future of Fat as Raw Material for Tissue Regneration,” (2007) pp. 215-219, Lippincott Williams & Wilkins, Inc. |
DiMuzio, Paul et al., “Development of a Tissue-Engineered Bypass Graft Seeded with Stem Cells,” Vasucular, vol. 14, No. 6, (2006) pp. 338-342, BC Decker, Inc. |
Drug Intelligence and Clinical Pharmacy, vol. 22, pp. 946-952, Dec. 1988, Dennis F. Thompson, et al., “Fibrin Glue: A Review of Its Preparation, Efficacy, and Adverse Effects as a Topical Hemostat”. |
Edlich, Richard F., George T. Rodeheaver, and John G. Thacker. “Surgical Devices in Wound Healing Management.” In Wound Healing: Biochemical & Clinical Aspects,ed. I. Kelman Cohen, Robert F. Diegelmann, and William J. Lindblad. 581-600. 1st ed., Vol. Philadelphia: W.B. Saunders Company, 1992). |
Eppley, et al., “Platelet Quantification and Growth Factor Analysis from Platelet-Rich Plasma: Implications for Wound Healing,” Plastic and Reconstructive Surgery, 114(6):1502-1508 (Nov. 2004). |
Epstein, G. H., R. A. Weisman, S. Zwillenberg, and A. D. Schreiber. “A new autologous fibrinogen-based adhesive for otologic surgery.” Ann Otol Rhinol Laryngol 95 (1 Pt 1 1986): 40-5. |
Fibrostik™ Plasma Concentrator, Attention Operating Surgeon, Cell Factor Technologies, Inc., Jul. 2003. |
First clinical results: Kuderma, H. and Helene Matras. “Die klinische Anwendung der Klebung van Nervenanastomosen mit Gerinnungssubstanzen bei der Rekonstruction verletzter peripherer Nerven.” Wein Klin Wochenschr 87 (15 1975): 495-501. |
Floryan, K. et al. “Home Study Program: Intraoperative Use of Autologous Platelet-Rich and Platelet-Poor Plasma for Orthopedic Surgery Patients” vol. 80, No. 4 (Oct. 2004) p. 667-674. |
Frasier, John K., et al., “Plasticity of human adipose stem cells toward endothelial cells and cardiomyocytes,” Nature Clinical Practice Cardiovascular Medicine, vol. 3, Supplement 1 (Mar. 2006) pp. S33-S37. |
Friesen, M.D., Robert, et al. “Blood Conservation During Pediatric Cardiac Surgery: Ultrafiltration of the Extracorporeal Circuit Volume After Cardiopulmonary Bypass.” Anesth. Analg 1993: 77-702-7. |
Galois, et al., “Cartilage Tissue Engineering: State-of-the-Art and Future Approaches,” Pathol Biol (Paris), 53(10), Dec. 2005. |
Gibble, J. W. and P. M. Ness. “Fibrin glue: the perfect operative sealant?” Transfusion 30 (8 1990): 741-7. |
Gimble, Jeffrey M., “Adipose-Derived Stem Cells for Regenerative Medicine,” Circulation Research (2007) pp. 1249-1260, American Heart Association, Inc. |
Gomillion, Cheryl T., et al., “Stem cells and adipose tissue engineering,” Biomaterials 27, Science Direct (2006) pp. 6052-6063, Elsevier. |
GPS® III System, GPS® III Platelet Separation System, Leadership through Technology, brochure, Jul. 2007 (8 sheets). |
GPS® System, “GPS® Platelet Concentrate System,” Cell Factor Technologies, Inc., Biomet Orthopaedics, Inc., (2004) (9 pages). |
GPS® System, “Shoulder Recovery with the GPS® Platelet Concentrate System, Rotator Cuff Surgical Techniques,” brochure, Cell Factor Technologies, Inc., Biomet Orthopaedics, Inc., (2004) 6 pages. |
GPS® System, “Shoulder Recovery with the GPS® Platelet Concentrate System, Rotator Cuff Surgical Techniques,” Cell Factor Technologies, Inc., Biomet Orthopaedics, Inc., (2004) 3 pages, http://www.cellfactortech.com/global—products.cfm, printed Sep. 16, 2005. |
GPS®II System, Gravitational Platelet Separation System, “Accelerating the Body's Natural Healing Process,” Cell Factor Technologies, Inc., Biomet Europe (2005) 16 pages, http://www.cellfactortech.com/global—products.cfm, printed Sep. 16, 2005. |
GPS®II System, Gravitational Platelet Separation System, “User Manual,” Cell Factor Technologies, Inc., Biomet Europe [date unknown] 13 pages, http://www.cellfactortech.com/global—products.cfm, printed Sep. 16, 2005. |
Grove, et al., “Plasticity of Bone Marrow-Derived Stem Cells,” Stem Cells: Concise Review, 22, Jan. 2004. |
Guilak, Frank, et al., “Adipose-derived adult stem cells for cartilage tissue engineering,” Biorheology 41 (2004) pp. 389-399, IOS Press. |
Harris, E.L.V. Concentration of the Extract. In. Protein Purification Methods: A Practical Approach Harris, E.L.V.; Angal, S.; Editors. (1989) Publisher: (IRL Press, Oxford, UK), pp. 67-69. |
Hartman, A. R., D. K. Galanakis, M. P. Honig, F. C. Seifert, and C. E. Anagnostopoulos. “Autologous whole plasma fibrin gel. Intraoperative procurement.” Arch Surg 127 (3 1992): 357-9. |
Harvest SmartPrep PRP-20 Procedure Pack, “Instructions for Use”. |
Harvest Technologies brochure, SmartPrep2 (2002). |
Hattori, et al., “Osteogenic Potential of Human Adipose Tissue-Derived Stromal Cells as an Alternative Stem Cell Source,” Cells Tissues Organs (2004) 178:2-12 Karger. |
Haynesworth, S.E. et al. “Mitogenic Stimulation of Human Mesenchymal Stem Cells by Platelet Releasate Suggests a Mechanism for Enhancement of Bone Repair by Platelet Concentrate” 48th Annual Meeting of the Orthopaedic Research Society Poster No. 0462 (2002). |
Hennis, H. L., W. C. Stewart, and E. K. Jeter. “Infectious disease risks of fibrin glue [letter].” Ophthalmic Surg 23 (9 1992): 640. |
Hernigou, et al., “Percutaneous Autologous Bone-Marrow Grafting for Nonunions. Influence of the Number and Concentration of Progenitor Cells,” Journal of Bone & Joint Surgery, 87-A(7):1430-1437 (Jul. 2005). |
Hom, D., et al. “Promoting Healing with Recombinant Human Platelet-Derived Growth Factor-BB in a Previously Irradiated Problem Wound.” The Laryngoscope, vol. 113 (pp. 1566-1671) Sep. 2003. |
Hood, Andrew G., et al., “Perioperative Autologous Sequestration III: A New Physiologic Glue with Wound Healing Properties,” (Jan. 1993) vol. 14 pp. 126-129. |
International Preliminary Examination Report and Written Opinion issued Aug. 31, 2010 for PCT/US2009/035564 claiming benefit of U.S. Appl. No. 61/078,178, filed Jul. 3, 2008, which priority is also claimed of said provisional case by U.S. Appl. No. 12/395,085, filed Feb. 27, 2009. |
International Preliminary Report on Patentability and Written Opinion mailed Oct. 13, 2011 for PCT/US2010/029957 which claims benefit of U.S. Appl. No. 12/417,789, filed Apr. 3, 2009. |
International Preliminary Report on Patentability completed Aug. 13, 2009 for PCT/US2008/004687 claiming benefit of U.S. Appl. No. 60/911,407, filed Apr. 12, 2007. |
International Search Report and Written Opinion mailed Jul. 2, 2008 for International Application No. PCT/US2008/004687 which claims priority to U.S. Appl. No. 60/911,407, filed Apr. 12, 2007. |
International Search Report and Written Opinion mailed Jul. 3, 2009 for PCT/US2009/035564 claiming benefit of U.S. Appl. No. 61/078,178, filed Jul. 3, 2008. |
International Search Report and Written Opinion mailed Jul. 30, 2010 for PCT/US2010/029957 which claims benefit of U.S. Appl. No. 12/417,789, filed Apr. 3, 2009. |
International Search Report and Written Opinion mailed Nov. 7, 2011 for PCT/US2011/045290 claiming benefit of U.S. Appl. No. 12/846,944, filed Jul. 30, 2010. |
International Search Report for International Application No. PCT/US/0316506 mailed Oct. 13, 2003 which claims benefit of U.S. Appl. No. 60/383,013, filed May 24, 2002. |
International Search Report for International Application No. PCT/US2007/012587 mailed Nov. 6, 2007 which claims benefit of U.S. Appl. No. 11/441,276, filed May 25, 2006. |
Ishida, et al., “Platelet-Rich Plasma With Biodegradable Gelatin Hydrogel Promotes Rabbit Meniscal Tissue Regeneration,” 52nd Annual Meeting of the Orthopaedic Research Society Paper No. 1035, 1 page (2006). |
Jackson, C. M. and Y. Nemerson. “Blood coagulation.” Annu Rev Biochem 49 (811 1980): 765-811). |
Jayadev, Suprya. “Trypsinization of Adherent Cells.” Aug. 8,1991. Web. Apr. 14, 2010 http://www.duke.edu/web/ceramide/protocols/0005.html. |
Johnstone, et al., “Autologous Mesenchymal Progenitor Cells in Articular Cartilage Repair”, Clinical Orthopaedics and Related Research 367S:S156-S162 (1999). |
Jorgensen, et al., “Stem Cells for Repair of Cartilage and Bone: The Next Challenge in Osteoarthritis and Rheumatoid Arthritis,” Annals of Rheumatic Diseases, Aug. 2000. |
Journal of Oral Maxillofacial Surgery, vol. 43, pp. 605-611, 1985, Helene Matras, M.D., “Fibrin Seal: The State of the Art”. |
Karpatkin, S., “Heterogeneity of Human Platelets. VI., Correlation of Platelet Function with Platelet Volume”, Blood, vol. 51, No. 2 (Feb. 1978). |
Kjaergard, H. K,, U. S. Weis-Fogh, H. Sorensen, J. Thiis, and I. Rygg. “A simple method of preparation o£ autologous fibrin glue by means of ethanol.” Surg Gynecol Obstet 175 (1 1992): 72-3. |
Kjaergard, H. K., Fogh Us Weis, and J. J. Thiis. “Preparation of autologous fibrin glue from pericardial blood.” Ann Thorac Sur 55 (2 1993): 543-4. |
Kumar, Vijay et al. “Stability of Human Thrombin Produced From 11 ml of Plasma Using the Thrombin Processing Device,” Journal of American Society of Extra-Corporeal Technology. JECT: 2005:37; 390-395. |
Kumar, Vijay et al. “Whole Blood Thrombin: Development of a Process for Intra-Operative Production of Human Thrombin.” Journal of American Society of Extra-Corporeal Technology. JECT: 2007; 39:18-23. |
Kumar, Vijay et al., “Autologous Thrombin: Intraoperative Production From Whole Blood.” Journal of American Society of Extra-Corporeal Technology. JECT: 2008; 40:94-98. |
Laryngoscope vol. 99, pp. 974-976, Sep. 1989, Kyosti Laitakari, M.D., et al., “Autologous and Homologous Fibrinogen Sealants: Adhesive Strength”. |
Laryngoscope, vol. 95, pp. 1074-1076, Sep. 1985, Karl H. Siedentop, M.D., et al., “Autologous Fibrin Tissue Adhesive”. |
Laryngoscope, vol. 96, pp. 1062-1064, Oct. 1986, Karl H. Siedentop, M.D., et al., “Extended Experimental and Preliminary Surgical Findings with Autologous Fibrin Tissue Adhesive Made from Patient's Own Blood”. |
Lasher, Lisa, M.D., “My Experience with PRP,” PowerPoint presentation, http://www.cellfactortech.com/global—products.cfm, printed Sep. 16, 2005. |
Lendeckel, Stefan, et al., “Autologous stem cells (adipose) and fibrin glue used to treat widespread traumatic calvarial defects: case report,” Journal of Cranio-Maxillofacial Surgery (2004) European Association for Cranio-Maxillofacial Surgery. |
Lerner, R. and N. S. Binur. “Current status of surgical adhesives.” J Surg Res 48 (2 1990): 165-81. |
Longas, Maria O., “An Improved Method for the Purification of Human Fibrinogen.” J. Biochem (1980) vol. 11, pp. 559-564. |
Lu, et al., “Bone Marrow Mesenchymal Stem Cells: Progress in Bone/Cartilage Defect Repair,” 19(1), Jan. 2002. |
Marrowstim Concentration System, Biomet Biologics, Inc., 20 pages (REV Feb. 15, 2008). |
Marx, Gerard, et al., “Heat Denaturation of Fibrinogen to Develop a Biomedical Matrix.” Journal of Biomedical Materials Research Part B: Applied Biomaterials (Apr. 2007) pp. 49-57. |
Masri, Marwan A., et al. “Isolation of Human Fibrinogen of High Purity and in High Yield Using Polyethylene Glycol 1000.” Thromb Haemostas (Struttgart) (1983) vol. 49 (2); pp. 116-119. |
Matras, Helene, H. P. Dinges, H. Lassmann, and B. Mamoli. “Zur nahtlosen interfaszikularen Nerventransplantation im Tierexperiment.” Wein Med Woschtr 122 (37 1972): 517-523. |
Minntech® Filtration Technologies Group, “Hemocor HPH® Hemoconcentrator,” Minntech Corporation (2004); http://www.minntech.com/ftg/products/hph/index.html, printed Jul. 15, 2004 (2 pages). |
Minntech® Filtration Technologies Group, “Medical Applications: Blood Filtration” Minntech Corporation (2004); http://www.minntech.com/ftg/industries/medical/blood—filter.html, printed Jul. 15, 2004 (1 page). |
Minntech® Filtration Technologies Group, “Renaflo® II Hemofilter,” Minntech Corporation (2004); http://www.minntech.com/ftg/products/renaflo/index.html, printed Jul. 15, 2004 (2 pages). |
Molnar, Amy, “Stem Cells from Muscles Can Repair Cartilage, Study Finds Genetically Engineered Muscle-Derived Stem Cells Improved Cartilage Repair in Rats”, American College of Rheumatology, (2005). |
Moretz, W., Jr., J Shea Jr., J. R. Emmett, and J Shea. “A simple autologous fibrinogen glue for otologic surgery.” Otolaryngol Head Neck Surg 95 (1 1986): 122-4. |
Nakagami, Hironori, et al., “Novel Autologous Cell Tehrapy in Ischemic Limb Disease Through Growth Factor Secretion by Cultured Adipose Tissue-Derived Stromal Cells,” Angiogenesis by Adipose Tissue-Derived Cells, (2005) pp. 2542-2547, American Heart Association, Inc. |
Nathan, Suresh et al., “Cell-Based Therapy in the Repair of Osteochondral Defects: A Novel Use for Adipose Tissue,” Tissue Engineering, vol. 9, No. 4 (2003) pp. 733-744 Mary Ann Liebert, Inc. |
Nilsson, et al., “Bone Repair Induced by Bone Morphogenetic Protein in Ulnar Defects in Dogs,” The Journal of Bone and Joint Surgery, vol. 68 B., No. 4, Aug. 1986. |
Orphardt, Charles E., “Denaturation of Proteins,” Virtual Chembook, Elmhurst College (2003) 3 pages. http://www.elmhurst.edu/˜chm/vchembook/568denaturation.html (web accessed Mar. 9, 2011). |
Otolaryngologic Clinics of North America, vol. 27, No. 1, pp. 203-209, Feb. 1994, Dean M. Toriumi, M.D., et al., “Surgical Tissue Adhesives in Otolaryngology—Head and Neck Surgery”. |
Parker, Anna M., et al., Adipose-derived stem cells for the regeneration of damaged tissues, Expert Opinion, Cell- & Tissue-based Therapy, Expert Opin. Biol. Ther. (2006) pp. 567-578 Informa UK Ltd. |
Planat-Bénard, V., et al., “Spontaneous Cardiomyocyte Differentiation From Adipose Tissue Stroma Cells,” Adipose-Derived Cell Cardiomyocyte (2004) pp. 223-229 American Heart Association, Inc. |
Ponticiello, Michael S., “A Rapid Technique for the Isolation and Concentration of Stem Cells from Human Bone Marrow”, Cell Factor Technologies, Inc. (2006) 2 pages. |
Rangappa, Sunil, M.D., “Transformation of Adult Mesenchymal Stem Cells Isolated From the Fatty Tissue Into Cardiomyocytes,” Adult Stem Cells Transformed into Cardiomyoctyes, (2003) pp. 775-779 Ann Thorac Surg. |
Rigotti, M.D., et al, “Clinical Treatment of Radiotherapy Tissue Damage by Lipoaspirate Transplant: A Healing Process Mediated by Adipose-Derived Adult Stem Cells,” Plastic and Reconstructive Surgery, Breast, PRS Journal vol. 119, No. 5, Stem Cell Therapy for Angiogenesis, (Pub. 2005) pp. 1409-1422. |
Rubin, M.D., et al, “Clinical Treatment of Radiotherapy Tissue Damage by Lipoaspirate Transplant: A Healing Process Mediated by Adipose-Derived Adult Stem Cells,” Plastic and Reconstructive Surgery, Discussion vol. 119, No. 5, Stem Cell Therapy for Angiogenesis, (2007) pp. 1423-1424. |
Sanal, M. “Does fibrin glue cause foreign body reactions? [letter].” Eur J Pediatr Surg 3 (3 1993): 190 (1 page). |
Sanal, M., H. Dogruyol, A. Gurpinar, and O. Yerci. “Does fibrin glue cause foreign body reactions?” Eu r J Pediatr Surg 2 (5 1992): 285-6. |
Schmidt, K.G., et al., “Labelling of Human and Rabbit Platelets with Indium-Oxine Complex”, 23:97-106 (1979). |
Schmidt, K.G., et al., “Preparation of Platelet Suspensions from Whole Blood in Buffer”, Scand. J. Hoemato, 23:88-96 (1979). |
Schäffler, Andreas, et al., “Concise Review: Adipose Tissue-Derived Stromal Cells—Basic and Clinical Implications for Novel Cell-Based Therapies,” Tissue-Specific Stem Cells, Stem Cells® (2007) pp. 818-827 AlphaMed Press. |
Semple, Elizabeth, PhD, et al. “Quality of Thrombin Produced From the Patient's Own Plasma Using the TPD Tradmark in Here, a New Thrombin-Processing Device.” Journal of American Society of Extra-Corporeal Technology. JECT: 2005; 37:196-200. |
Sierra, D. H. “Fibrin sealant adhesive systems: a review of their chemistry, material properties and clinical applications.” J Biomater Appl 7 (4 1993): 309-52. |
Sigma-Aldrich® Alkaline Phosphatase (Procedure No. 85), drug fact sheet, (2003) pp. 1-2, Sigma-Aldrich, Inc. |
Silver, Frederick H., et al., “Review Preparation and use of fibrin glue in surgery.” Biomaterials 16 (1995) pp. 891-903. |
Solem, Jan Otto, et al., “Hemoconcentration by Ultrafiltration During Open-Heart Surgery,” Scand J Thor Cardiovasc Surg 22:271-274, 1988. |
Sutton, Robin G., et al. “Comparison of Three Blood-Processing Techniques During and After Cardiopulmonary Bypass.” Ann Thorac Surg (1993) vol. 56; pp. 941-943. |
Swift, Mathew J., et al., “Characterization of Growth Factors in Platelet Rich Plasma,” 1-Cell Factor Technologies, http://www.cellfactortech.com/global—products.cfm, printed Sep. 16, 2005. |
Symphony II Platelet Concentrate System/PCS brochure; “Increasing bone graft bioactivity through reproducible concentrations of natural growth factors,” DePuy (Jan. 2003). |
Takahashi, Kazutoshi et al., “Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors,” Cell, (2007) pp. 1-12, Elsevier Inc. |
The American Journal of Surgery, vol. 168, pp. 120-122, Aug. 1994, Roy L. Tawes, Jr., M.D., et al., “Autologous Fibrin Glue: The Last Step in Operative Hemostatis”. |
The American Surgeon, vol. 55, pp. 166-168, Mar. 1989, William D. Spotnitz, M.D., et al., “Successful Use of Fibrin Glue During 2 Years of Surgery at a University Medical Center”. |
The Sports Medicine Center, “Knee Cartilage Implantation”, Carticel™, “Autologous Cultured Chondrocyte Implantation”, http://www.orthoassociates.com/carticel.htm (printed Apr. 6, 2006). |
The Stone Clinic, “Platelet Rich Plasma (PRP)”, web site printed May 2006. |
Vox Sanquinis, vol. 68: 82-89, Feb. 1995, Boomgaard Et. al, Pooled Platelet Concentration Prepred by the . . . . |
Weis-Fogh, U. S. “Fibrinogen prepared from small blood samples for autologous use in a tissue adhesive system.” Eur Surg Res 20 (5-6 1988): 381-9. |
Weisman, MD., Robert A., “Biochemical Characterization of Autologous Fibrinogen Adhesive,” Laryngoscope 97: Oct. 1987; pp. 1186-1190. |
Wiseman, David M., David T. Rovee, and Oscar M. Alverez. “Wound Dressings: Design and Use.” In Wound Healing: Biochemical & Clinical Aspects,ed. I. Kelman Cohen, Robert F. Diegelmann, and William J. Lindblad. 562-580. 1st ed., Vol. Philadelphia: W. B. Saunders Company, 1992). |
Woodell-May, et al., “Producing Accurate Platelet Counts for Platelet Rich Plasma: Validation of a Hematology Analyzer and Preparation Techniques for Counting,” Scientific Foundation, Journal of Carniofacial Surgery 16(5):749-756 (Sep. 2005). |
Written Opinion of the International Preliminary Examining Authority mailed Mar. 17, 2009 for International Application No. PCT/US2008/004687 which claims priority to U.S. Appl. No. 60/911,407, filed Apr. 12, 2007. |
Yoon, Eulsik, M.D., Ph.D., et al., “In Vivo Osteogenic Potential of Human Adipose-Derived Stem Cells/Poly Lactide-Co-Glycolic Acid Constructs for Bone Regneration in a Rat Critical-Sized Calvarial Defect Model,” Tissue Engineering, vol. 13, No. 3 (2007) pp. 619-627 Mary Ann Liebert, Inc. |
Zhang, Duan-zhen, et al., “Transplantation of autologous adipose-derived stem cells ameliorates cardiac function in rabbits with myocardial infarction,” Chinese Medical Journal, vol. 120, No. 4 (2007) pp. 300-307 General Hospital of Shenyang Military Region, Shenyang, China. |
Zuk, Patricia A., Ph.D., “Multilineage Cells from Human Adipose Tissue: Implications for Cell-Based Therapies,” Tissue Engineering, vol. 7, No. 2, (2001) pp. 211-228 Mary Ann Liebert, Inc. |
“Caps for Corning® and Costar® Plastic Labware,” Technical Bulletin. (Dec. 2008) Corning, Incorporated. |
“Centrifuge Tubes” Corning Costar brochure. 1996/1997 Catalog pp. 76-77. |
“Clotalyst® Autologous Clotting Factor” brochure. (Aug. 15, 2008) Biomet Biologics. |
“Corning® 15 and 50 mL Centrifuge Tubes,” Life Sciences. (Jun. 2005) Corning Incorporated. |
“Letter CryoSeal FS System. Vaccines, Blood & Biologics,” letter. (Jul. 26, 2007) FDA U.S. Food and Drug Administation. http://www.fda.gov/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/PremarketApprovalsPMAs/ucm091631.htm (Web accessed Aug. 12, 2011). |
“Plasmax® Plasma Concentration System” brochure. (Jun. 15, 2008) Biomet® Biologics. |
“Prosys PRP Kit,” brochure Tozai Holdings, Inc. http://tozaiholdings.en.ec21.com/Prosys—PRP—Kit--5467051—5467061.html Printed from Web Aug. 24, 2011. |
“Prosys PRP Kit,” Tozai Holdings, Inc. EC21 Global B2B Marketplace http://www.ec21.com/product-details/Prosys-PRP-Kit--5467061.html Printed from Web Jul. 18, 2011. |
DeUgarte, M.D., Daniel A., et al., “Future of Fat as Raw Material for Tissue Regeneration,” (Feb. 2003) pp. 215-219, Lippincott Williams & Wilkins, Inc. |
GPS®ll System, Gravitational Platelet Separation System, “Accelerating the Body's Natural Healing Process,” Biomet Biologics (Jul. 15, 2006) 16 pages. |
International Preliminary Report on Patentability mailed Jan. 26, 2012 for PCT/US2010/041942 claiming benefit of U.S. Appl. No. 12/504,413, filed Jul. 16, 2009. |
International Search Report and Written Opinion mailed Aug. 9, 2011 for PCT/US2011/031954 claiming benefit of U.S. Appl. No. 12/758,127, filed Apr. 12, 2010. |
Rigotti, M.D., et al, “Clinical Treatment of Radiotherapy Tissue Damage by Lipoaspirate Transplant: A Healing Process Mediated by Adipose-Derived Adult Stem Cells,” Plastic and Reconstructive Surgery, Breast, PRS Journal vol. 119, No. 5, Stem Cell Therapy for Angiogenesis, (Apr. 15, 2007) pp. 1409-1422. |
Sanal, M. “Does fibrin glue cause foreign body reactions? [letter].” Eur J Pediatr Surg 3.(1992): 190 (1 page). |
Japanese Office Action mailed Sep. 9, 2014 for Japan Patent Application No. 2012-520742,which claims benefit of PCT/US2010/041942 filed Jul. 14, 2010, which claims benefit of U.S. Appl. No. 12/504,413, filed Jul. 18, 2009. |
Chinese Office Action mailed Jun. 30, 2014 for Chinese Patent Application No. 201080019707.7, which claims benefit of PCT/US2010/029957 filed Apr. 5, 2010, which claims benefit of U.S. Appl. No. 12/417,789, filed Apr. 3, 2009. |
Japanese Office Action mailed Sep. 9, 2014 for Japan Patent Application No. 2012-520742,which claims benefit of PCT/US2010/041942 filed Jul. 14, 2010, which claims benefit of U.S. Appl. No. 12/504,413, filed Jul. 16, 2009. |
Minivalve international: duckbill valves—du 054.001 sd, <http://www.minivalve.com/htm/DV054.htm>, Accessed Jun. 30, 2014, 1 page. |
Momentive Silopren*LSR 2050, Jun. 30, 2014, 3 pages. |
Vernay Product Information Sheet, Umbrella Check Valve, Part No. V251010200, Jul. 2013, 2 pages. |
Chinese Office Action mailed Nov. 21, 2014 for Chinese Patent Application No. 201280030026.X. |
Number | Date | Country | |
---|---|---|---|
20110014705 A1 | Jan 2011 | US |